Publication date: December 2026 Source: The Lancet Regional Health - Europe, Volume 71 Author(s): Ali Ahmed, Andrew J.S. Coats, Michael Böhm, Stefan D. Anker, John G.F. Cleland, Gregg C. Fonarow
Clone-censor weighting and dementia risk after statin initiation in diabetes: when the analyzed population is no longer the observed population. // The Lancet Regional Health - Europe. – URL: https://www.sciencedirect.com/science/article/pii/S266677622600339X?dgcid=rss_sd_all
Clone-censor weighting and dementia risk after statin initiation in diabetes: when the analyzed population is no longer the observed population. The Lancet Regional Health - Europe. https://www.sciencedirect.com/science/article/pii/S266677622600339X?dgcid=rss_sd_all
“Clone-censor weighting and dementia risk after statin initiation in diabetes: when the analyzed population is no longer the observed population.” The Lancet Regional Health - Europe.
@article{article69291,
title = {Clone-censor weighting and dementia risk after statin initiation in diabetes: when the analyzed population is no longer the observed population},
journal = {The Lancet Regional Health - Europe},
url = {https://www.sciencedirect.com/science/article/pii/S266677622600339X?dgcid=rss_sd_all}
}
Abstract Aim Discretionary foods and beverages contribute to poor diet quality and chronic disease. In Australia, intake exceeds dietary guideline recommendations and is unlikely to improve without substantial intervention. We examined...
ABSTRACT Background Ultra‐processed foods (UPFs) are a leading contributor to diet‐related chronic disease and socio‐ecological harm. Despite increasing recognition of these impacts, regulatory responses remain fragmented, focused on...